|
Volumn 76, Issue 1-2 SUPPL. 1, 1995, Pages
|
High-dose fluvastatin and bezafibratecombination treatment for heterozygous familial hypercholesterolemia
a a b a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BEZAFIBRATE;
CHOLESTEROL;
COLESTYRAMINE;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
TRIACYLGLYCEROL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERANCE;
FAMILIAL HYPERCHOLESTEROLEMIA;
HUMAN;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
ANTICHOLESTEREMIC AGENTS;
BEZAFIBRATE;
CHOLESTEROL;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CHOLESTYRAMINE;
DELAYED-ACTION PREPARATIONS;
DRUG COMBINATIONS;
FATTY ACIDS, MONOUNSATURATED;
HETEROZYGOTE;
HUMANS;
HYDROXYMETHYLGLUTARYL COA REDUCTASES;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPOPROTEINEMIA TYPE II;
INDOLES;
KIDNEY;
LIVER;
LONGITUDINAL STUDIES;
PLACEBOS;
SAFETY;
TRIGLYCERIDES;
|
EID: 0029053683
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(05)80023-2 Document Type: Article |
Times cited : (32)
|
References (16)
|